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Introduction: Schizophrenia (SZ) and bipolar disorder (BD) are neurodegenerative 
psychotic disorders hallmarked by reductions in gray and white matter volume. Limitations 
in neuroimaging have led to the use of OCT to study retinal layer biomarkers and their 
relation to brain pathology. This thesis includes a meta-analysis of current literature and an 
exploratory analysis of retinal layer thickness in relation to SZ and BD.  
 
 
Methods: For the meta-analysis, twelve articles were identified using PubMed, Web of 
Science, and Cochrane database. Diagnostic groups were proband (SZ and BD combined), 
SZ only, BD only, and healthy control (HC) eyes. Analyses utilized fixed and random effects 
models, in addition to assuring that bias was adjusted for and that results were cross-
validated. Statistical analyses were performed using the “meta” package in R, with results 
reported as standard mean differences (SMD). The exploratory analysis included a total of 38 
subjects (24 probands and 14 HC). Retinal measures were co-varied for age, sex, race, body 
mass index (BMI), and best-corrected visual acuity (BCVA). Correlations between retinal and 
clinical and cortical measures were also performed. Clinical data included illness duration, 
symptom severity, antipsychotic dosage, and smoking status. Neuroimaging data included 
gray matter (GM) thickness, gray matter volume, and intracranial volume (ICV). Linear 
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effects and mixed effects models were used to study mean eye and right/left eye measures, 
respectively.  Statistical analysis was done in R.  
Results: A total of 820 patient eyes (541 SZ and 279 BD) and 904 HC eyes were used for 
the meta-analysis. Compared to HC eyes, probands, SZ, and BD eyes showed significant 
thinning the peripapillary retinal nerve fiber layer (RNFL), with atrophy greatest in the nasal, 
temporal, and superior regions. In addition, all diagnostic groups demonstrated significant 
reductions in the combined ganglion cell layer and inner plexiform layer (GCL-IPL) 
compared to HC. No significant differences were found for choroidal and macular measures. 
No significant relationships were seen from meta-regression analysis for clinical measures. 
For the exploratory analysis, retinal measures from a total of 24 probands (18 SZ and 6 BD) 
and 14 HC was studied. Compared to HC, probands showed reductions in overall RNFL in 
mean eye measures, while increases in the inner and outer RNFL were seen in left eye 
measures. No significant group differences were seen in the GCL, IPL, and inner nuclear 
layer (INL). The outer plexiform layer (OPL) showed significant thickening in probands and 
SZ compared to HC for all eye measures. Probands showed trending reductions in the outer 
nuclear layer (ONL) in the left eye compared to HC. No significant correlations were found 
between retinal layers and illness duration, overall PANSS (Positive and Negative Syndrome 
Scale) score, PANSS negative symptom subscore, and smoking status. PANSS positive 
symptom subscore showed significant and trending negative correlations to the RNFL and 
GCL, respectively. Antipsychotic medication dosage displayed a trending negative 
relationship with the IPL. GM thickness showed a significant and trending negative 
correlation to the RNFL and ONL, respectively. Furthermore, a trending inverse 
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relationship was observed between GM volume and the OPL. Finally, ICV demonstrated a 
trending and significant negative relationship with GCL and OPL thickness, respectively.  
Conclusion: The meta-analysis showed that atrophy in RNFL and GCL-IPL measures are 
widely associated with psychosis. Furthermore, it supports previous findings of gray and 
white matter reductions in SZ and BD. The exploratory analysis showed psychosis-
associated reductions in the RNFL and ONL layers, consistent with previous literature. 
Contradictory findings, the thickening of the ONL, can be attributed to the conflicting 
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Schizophrenia and Bipolar Disorder  
Schizophrenia (SZ) and bipolar disorder (BD) are serious and progressive mental illnesses 
characterized by cognitive, functional, and social deficits. Both present in late-adolescence or 
early adulthood and demonstrate psychotic or manic symptoms (American Psychiatric 
Association, 2013; Merikangas et al., 2007). Symptoms of schizophrenia are categorized as 
either positive or negative. Positive symptoms include delusions, hallucinations, and 
disorganized thoughts and behavior, while negative symptoms comprise of flat affect, alogia 
(difficulty with speaking), and avolition (inability to initiate or perform goal-directed 
behavior). In bipolar disorder, there is an alternation between episodes of mania and 
episodes of depression (American Psychiatric Association, 2013). The pathophysiology of 
either disorder is not entirely known, but recent studies have shown that they share a similar 
pathophysiology. These similarities include gray and white matter atrophy, glial cell 
dysfunction, and increased inflammatory markers (DeLisi et al., 2006; Kempton et al., 2008; 
Moorhead et al., 2007; Najjar et al., 2013). Therefore, imaging techniques studying the brain, 
structural magnetic resonance imaging (MRI), and the eye, retinal optical coherence 
tomographic (OCT), can help to illuminate the general underlying neurobiology and 
pathological mechanisms of psychosis.  
 While advancements have been made to understand SZ and BD with neuroimaging 
techniques, there are limitations. Image resolution, cost, and accessibility to certain brain 
regions limit what information researchers can collect and analyze. Because of this, OCT 
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analysis of retinal cell layers has been gaining traction as a non-invasive and high-resolution 
tool to study new biomarkers in neurological disorders (London et al., 2013).  
 
Optical Coherence Tomography 
OCT was first developed in the 1990s as an in-vivo imaging technique. It works similarly to 
ultrasound, utilizing backscattered light to form a 2D, real-time image of tissue (Huang et al., 
1991). Over time, OCT has become the standard of care for imaging of the optic nerve and 
macular region of the retina, and it is used for the diagnosis of various ophthalmic diseases, 
most commonly age-related macular degeneration (AMD) and diabetic retinopathy (DR) 
(Das, 2016; de Barros Garcia et al., 2017). Retinal OCT imaging has also been utilized in the 
study of neurological disorders that have associated vision loss, such as Alzheimer’s Disease, 
Parkinson’s Disease, and Multiple Sclerosis (MS) (Almarcegui et al., 2010; Lu et al., 2010; Yu 
et al., 2014). These studies have shown the efficacy of OCT imaging in understanding both 
underlying neurodegenerative pathways as well as providing potential early diagnoses. 
Finally, investigations into stroke and cardiovascular disease (such as myocardial infarction) 
have demonstrated links with impaired retinal architecture (Kromer et al., 2018; Osiac et al., 
2014).  
Some studies have analyzed alterations in retinal thickness and volume in SZ and 
BD, with particular interest in the retinal nerve fiber and ganglion cell layers (Mehraban et 
al., 2016; Steven M. Silverstein et al., 2017). Advances in OCT technology from the first-
generation time domain (TD) OCT to spectral domain (SD) and swept source (SS) OCT 
have greatly improved spatial resolution of the images and have allowed for examination into 




The Visual Pathway  
Because the retina shares embryological origins with the brain, it has been increasingly 
studied as a “window” into the underlying pathophysiology of neurologic disorders (Chu et 
al., 2012; Mancall & Gray, 2011). 
 The retina is the sensory neural layer of the eye and functions to detect and provide 
initial analysis of visual information. It contains 6 cell types and 10 layers (Figure 2). From 
the vitreous body, the layers are as follows: internal limiting membrane (ILM), retinal nerve 
fiber layer (RNFL), ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer 
(INL), outer plexiform layer (OPL), outer nuclear layer (ONL), external limiting membrane 
(ELM), photoreceptor layer, and retinal pigmented epithelium (RPE). The ILM acts as the 
the glial boundary between the retina and vitreous body, while the ELM is a junction 
between the processes of glial cells and photoreceptor cell processes. The RPE forms a tight 





Figure 1: Retinal layer diagram. Illustration of the retinal layers and cell types. From Gray’s 
Clinical Neuroanatomy: The Anatomic Basis for Clinical Neuroscience.  
 
As light enters the eye, it travels through all the layers of the transparent retina to the 
photoreceptors, whose cell bodies are contained within the ONL. There are two types of 
photoreceptors: rods and cones. Rods are responsible for low-light (scoptic) vision, but have 
low spatial acuity and do not facilitate color vision. Cones come in three types, red, blue, and 
green, and allow for photopic vision: high spatial resolution and color vision in well-lit 
conditions. From there, the visual signal is transmitted to the synaptic arrangements between 
photoreceptor, bipolar, and horizontal cells of the OPL. Bipolar and horizontal cells are 
interneurons, and respectively, they function to help transmit signals from the photoreceptor 
cells to the ganglion cells and to facilitate connections between rod and cone photoreceptor 
cells. After the OPL are the cell bodies of the amacrine, bipolar, and horizontal cells in the 
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INL. These cells forward the visual signal to the IPL and across synapses between the axons 
of bipolar cells and dendrites of ganglion cells.  
The GCL comprises of the cell bodies of ganglion cells and nuclei of amacrine cells. The 
unmyelinated axons of the ganglion cells make up the RNFL, and these fibers coalesce at the 
optic nerve and primarily to the lateral geniculate nucleus (LGN) of the thalamus.  
 
Figure 2: Connections between the eye and the brain. From The retina as a window to the brain 
– from eye research to CNS disorders. 
 
Visual Deficits in Psychosis  
SZ and BD are associated with vision deficits and aberrations in the visual pathway. 
Perceptual organization, the ability to group data into patterns, has been shown to be 
impaired in SZ, manifesting as difficulty in processing facial cues, social cognition, working 
memory, and selective attention (Silverstein & Keane, 2011). In a review by Chen et al. 
(2011), poor spatial and temporal eye-tracking (motion processing) has been associated with 
	
	 6	
SZ. Furthermore, SZ and BD have been linked with deficits in emotional facial feature 
recognition (Schaefer et al., 2010; Turetsky et al., 2007).  Abnormal visual motion perception 
has also associated with BD, along with visual masking impairments (Chkonia et al., 2012; 
O’Bryan et al., 2014). Literature analyzing the cognitive aspects of visual deficits in SZ and 
BD are extensive, but  
further research is warranted into related neurobiological mechanisms.   
The aim of this thesis is two-fold: to conduct a meta-analysis of current literature on 
retinal imaging biomarkers in SZ and BD and to undergo an exploratory analysis on a 
sample of participants with SZ and VD. The meta-analysis incorporates materials from a 
published co-first author paper (Lizano et al., 2020), where the thesis author made significant 
research and writing contributions.  This meta-analysis will summarize current literature in 
the field, describe gaps in understanding, and uncover areas of analysis for use in the 
exploratory study. The aim of the exploratory analysis is to illuminate aberrant retinal 
cytoarchitecture and associations to cortical and clinical measures in SZ and BD. Because the 
RNFL contains fibers that form the optic nerve and the GCL contains the ganglion cell 
bodies, we hypothesize that thinning would be seen in these layers leading to overall retinal 
thickness reductions. Furthermore, we hypothesize that positive correlations would be seen 
between cortical measures and retinal layer thicknesses, as gray and white matter integrity 












This section has been adapted from the author’s co-first author publication: Lizano, P., 
Bannai, D., Lutz, O., Kim, L. A., Miller, J., & Keshavan, M. (2020). A Meta-analysis of 
Retinal Cytoarchitectural Abnormalities in Schizophrenia and Bipolar Disorder. 




Two investigators (PL and DB) comprehensively searched and identified retinal OCT SZ 
and BD studies through PubMed, Web of Science, and the Cochrane Collaboration’s 
Database of Systematic Review in July 2018 and again in December 2018. The Preferred 
Report Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were 
followed (Appendix Table 1; Moher, Liberati, Tetzlaff, & Altman, 2009). Search strategies 
used were “schizophrenia OR psychosis OR bipolar disorder” AND “optical coherence 
tomography OR retinal nerve fiber layer thickness OR macula volume OR ganglion cell layer 
OR choroidal layer”. Manual evaluation of citations from selected papers added more 
relevant studies. Articles were screened for eligibility via inclusion and exclusion criteria. 
Inclusion criteria for studies were: 
1. OCT assessment in patients with a diagnosis of SZ or BD defined by the DSM-4, 
Diagnostic Interview for Psychosis (DIP), or a psychiatrist (American Psychiatric 
Association, 2013) 
2. Cross-sectional or prospective studies 
3. Pertinent data within article or available upon request 
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4. English language 
 
Articles were excluded if they fit one or more of the exclusion criteria: 
1. No control group 
2. No peripapillary RNFL thickness measurements  
3. Significant overlap in study population 
4. Data measurements were in a different format than mean and standard deviation 
values 
 
Assessment of Quality 
The Newcastle-Ottawa Scale (NOS) provided a structured format in order to evaluate the 
strength of articles included in meta-analysis based on selection of the study groups, 
comparability of groups, and data measure parameters. An overall quality score was defined 
as the number of criteria met by each study and was done by the two raters, PL and DB 








A total of 38 participants with SZ (n =11), schizoaffective disorder (SAD, n = 7), BD (n = 
6), and healthy controls (HC, n = 14) were included for a preliminary analysis of retinal 
segmentation in psychosis. The diagnostic groups were well matched for age, race, best-
corrected visual acuity (BCVA), right visual acuity (VA), and left VA. BCVA is the visual 
acuity measured when participants wore their normal corrective glasses or lenses. Smoking 
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status was measured using the Fagerstrom Test for Nicotine Dependence (FTND), where 
answers to six yes or no questions are rated (Fagerström, 1978). The sum of the scores from 
this test was used as the smoking status clinical measure. Scores for the Positive and 
Negative Syndrome Scale (PANSS), a medical scale used to measure symptom severity in 
patients with schizophrenia, were available for 16 of the 24 probands (Kay et al., 1987).  
 
OCT Data 
Retinal OCT scans were acquired at Massachusetts Eye and Ear Institute using a Heidelberg 
Spectralis SD-OCT scanner. In addition, OCT angiography (OCT-A) images were collected 
with a Triton DRI-OCT swept source scanner with a 6x6mm grid centered on the fovea. An 
Early Treatment Diabetic Retinopathy Study (ETDRS) grid, shown in Figure 3, was centered 






Figure 3: Illustration of the ETDRS grid. Regions marked (1) comprise the central region. Regions 
marked (2)-(5) comprise the inner ring, and regions (6)-(9) make up the outer ring. Figure taken from 
(Demirkaya et al., 2013).  
MRI 
Structural T1-weighted magnetization prepared rapid gradient echo (MPRAGE) images were 
gathered using a General Electric 3 Tesla scanner. Freesurfer 6.0 was used to pre-process the 
structural images and to parcel out various cortical structures and their measures. The three 
cortical markers utilized in the pilot study were gray matter (GM) thickness, GM volume, and 
total intra-cranial volume (ICV). 
 
Statistical Analysis 
The meta-analysis was conducted using RStudio software and the ‘metafor’ package. Meta-
regression analysis utilized the ‘metareg’ package. For the pilot study, independent sample t-
tests were used to compare demographics. Eye data was collected from each eye, right (OD) 
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and left (OS), and mean values for each region were calculated by combining OD and OS 
measures. Analysis using the mean eye segmentation values were run with linear model to 
assess differences in retinal layer thicknesses. A linear mixed effects model was utilized for 
individual eye data, with fixed effects being age, sex, race, BMI, and BCVA. Because 
segmentation data within each patient varied between each eye, the segmentation data for the 







This section, including Figures 4-10 and Table 1, has been adapted from the author’s co-first 
author publication: Lizano, P., Bannai, D., Lutz, O., Kim, L. A., Miller, J., & Keshavan, M. 
(2020). A Meta-analysis of Retinal Cytoarchitectural Abnormalities in Schizophrenia and 




Figure 4 summarizes the selection of studies for this meta-analysis. One hundred and eighty-
two papers were identified from searching through online databases, and one paper was 
found from an outside source. Seventy-four articles remained after removal of duplications, 
and twenty-two of those were full-text papers. From there, 10 were excluded: two papers 
were commentary, five overlapped with other papers, one had a sample size (SZ or BD) less 
than 10 subjects, one was a retinal vascular study, and one did not contain necessary data for 
analysis. Twelve studies were eligible for qualitative and quantitative meta-analysis, 
containing a pooled sample of 521 probands (315 SZ and 206 BD) and 496 healthy controls. 
After selection, two independent raters, DB and PL, utilized the Newcastle Ottawa Scale to 
assess the quality of each study, shown in Table 1. Table 1 also includes other data 
parameters such as diagnostic criteria, number of eye hemispheres with data published, and 
demographics data for patient and control groups.  An intra-class correlation (ICC) analysis 
was performed to test the rater reliability. NOS scores were above 6 for all studies, with a 
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mean score of 6.63. Finally, the ICC value was 0.835, with a confidence interval from 0.53 to 












Differences in Peripapillary RNFL 
The peripapillary RNFL was studied in overall and subfield regions.  For overall peripapillary 
RNFL, there were twelves studies analyzed with a total of 820 eyes from probands (541 SZ 
and 279 BD) and 904 eyes from healthy controls (HC, 575 from SZ and 329 from BD 
studies). A significant reduction of thickness in the overall peripapillary RNFL was seen in 
probands (SMD = -0.74, CI = -1.15 to -0.33, p = 0.002), SZ (SMD = -0.51, CI = -0.85 to -
0.17), and BD (SMD = -1.06, CI = -2.11 to 0) eyes compared to controls (Figure 5). The 
funnel plot, indicating whether or not publication bias is present in the sample, did not 
indicate any bias upon qualitative assessment (Appendix Figure 1A). Meta-regression analysis 
of age, sex, disease duration, OCT device, and NOS score did not show confounding effects 
with layer thickness (Appendix Table 1). Covariates such as severity of psychosis, smoking 
status, and antipsychotic dosage did not have meta-regressions performed as the sample 
sizes were not large enough. 
 
Figure 5: Meta-analysis data for overall peripapillary RNFL. Forest plots with fixed and random 
effects as well as standardized mean difference (SMD) are given for RNFL data in probands, SZ (group 
1) and BD (group 2). “Total” indicates the number of eyes whose measures are used to calculate mean 
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difference. Horizontal bars in the forest plot indicate the 95% confidence intervals (CI). Size of the 
square indicates the weight for each study.  
 
The same twelve studies included measurements for nasal and temporal peripapillary RNFL 
thickness. Compared to HC, there was significant thinning in the nasal RNFL in probands 
(SMD = -0.26, CI = -0.36 to -0.17, p < 0.001), SZ (SMD = -0.28, CI = -0.52 to -0.04), and 
BD (SMD = -0.25, CI = -0.41 to -0.09) eyes (Figure 6A). The funnel plot indicated no 
publication bias (Appendix Figure 1B). For the temporal RNFL, significant thinning was 
seen in proband (SMD = -0.23, CI = -0.40 to -0.06, p < 0.001) and SZ (SMD = -0.19, CI = 
-0.31 to -0.07) eyes, but not for BD eyes (SMD = -0.28, CI = -0.67 to 0.10, Figure 6B). Trim 
and fill method analysis was utilized to correct for publication bias observed in the funnel 
plot.  Only the effect for probands remained significant after this correction (SMD = -0.20, 








Figure 6. Meta-analysis data for (A) nasal and (B) temporal RNFL. Forest plots with fixed and 
random effects as well as SMD are given for RNFL data in probands, SZ (group 1) and BD (group 2). 
“Total” indicates the number of eyes whose measures are used to calculate mean difference. Horizontal 
bars in the forest plot indicate the 95% CI. Size of the square indicates the weight for each study.  
 
Seven studies were included for analysis of the superior and inferior peripapillary RNFL, 
comprising of 460 patient eyes (320 SZ and 140 BD) and 514 HC eyes (374 from SZ and 140 
from BD studies). In the superior RNFL, a significant decrease in thickness was seen in 
proband eyes compared to HC (SMD = -0.41, CI = -0.77 to -0.06, p = 0.03), but after adjusting 
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for publication bias, this effect was lost (Figure 7A, Appendix Figure 1D). Significant 
reductions were seen in BD eyes (SMD = -0.59, CI =-0.83 to -0.35) but not in SZ eyes (SMD 
= -0.34, CI = -0.88 to 0.20, Figure 7A). For the inferior RNFL, a trending reduction in 
thickness was found in proband eyes compared to HC (SMD = -0.33, CI = -0.69 to 0.03, p 
=0.065), but the results were lost after adjustment for publication bias (SMD = -0.059, CI = -
0.45 to 0.33, p = 0.74, Figure 7B, Appendix Figure 1E). Similar to the superior RNFL, 
significant thinning was observed in BD eyes (SMD = -0.67, CI = -0.91 to -0.43) but not in 
SZ eyes (SMD = -0.18, CI = -0.63 to 0.28, Figure 7B).  
 
Figure 7. Meta-analysis data for (A) superior and (B) inferior RNFL. Forest plots with fixed and 
random effects as well as SMD are given for RNFL data in probands, SZ (group 1) and BD (group 2). 
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“Total” indicates the number of eyes whose measures are used to calculate mean difference. Horizontal 
bars in the forest plot indicate the 95% CI. Size of the square indicates the weight for each study.  
 
 
Differences in GCL-IPL, GCC, and GCL 
Four of the twelve studies reported a combined GCL-IPL measure, with a total of 329 eyes 
from probands (226 SZ and 103 BD) and 331 eyes from HC (228 from SZ and 103 from 
BD studies). One study, Celik et al 2016, provided separate GCL and IPL volume 
measurements, which were combined to provide a “GCL-IPL” value. Khalil et al 2017 gave 
the ganglion cell complex (GCC) measurement; this value was separated from the RNFL 
measurement given to calculate a “GCL-IPL” value. A significant reduction in GCL-IPL 
volume was observed between probands and HC (SMD = -0.39, CI = -0.55 to -0.24, p < 
0.001), SZ and HC (SMD= -0.44, CI = -0.63 to -0.26) and BD and HC (SMD = -0.28, CI = 
-0.56 to -0.01, Figure 8A). The funnel plot indicated slight publication bias, and after 
adjustment via the trim and fill method, the results remained significant (SMD = -0.44, CI = 
-0.58 to =0.31, p < 0.001) (Appendix Figure 2A).  Meta-regression analyses co-varying for 
age, sex, OCT device, and NOS score reported no relation to GCL-IPL volume (Appendix 
Table 1). Other factors, such as disease duration, severity of psychosis, smoking status, and 
antipsychotic dosage, were not analyzed due to too small of a sample size.  
For the GCC, two studies were analyzed with a total of 103 BD eyes and 103 HC 
eyes. Significant thinning was seen (SMD = -0.94, CI = -1.23 to -0.65, p < 0.001, Figure 8B), 
and no publication bias was qualitatively seen in the funnel plot (Appendix Figure 2B).  
Two studies (one SZ and one BD) were included for analysis of GCL volume for a 
total sample of 248 eyes from probands (162 SZ and 86 BD) and 250 eyes from HC (164 
from SZ and 86 from BD studies). No significant reduction in GCL volume was observed 
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between probands and HC (SMD = -1.83, CI = -9.53, 5.88, p = 0.20, Figure 8C). In SZ and 
BD, reductions in volume were seen, but because of the high levels of heterogeneity 
between the two studies, no overall significance was reported. The funnel plot indicated 
publication bias, but there were not enough samples to perform trim and fill method analysis 
(Appendix Figure 2C).  
 
Figure 8: Meta-analysis data for (A) GCL-IPL, (B) GCC, and (C) GCL. Forest plots with fixed 
and random effects as well as SMD are given for RNFL data in probands, SZ (group 1) and BD (group 
2). “Total” indicates the number of eyes whose measures are used to calculate mean difference. 






Differences in Choroidal Thickness 
Four studies, with a total of 330 eyes from probands (221 SZ and 109 BD eyes) and 310 eyes 
from HC (201 from SZ and 109 from BD studies), were analyzed to study average choroidal 
thickness (CT). No differences were seen between probands and HC (SMD = -0.01, CI = -
0.43 to 0.42, p = 0.96, Figure 9A). Furthermore, no significant thinning was found in SZ 
eyes (SMD = -0.09, CI = - 2.31 to 2.73) and in BD eyes (SMD = -0.16, CI = 0.10 to 0.43, 
Figure 9A). Qualitative assessment indicated publication bias, and after adjustment, no 
significant differences arose between probands and controls (SMD = -0.25, CI = -0.71 to 
0.20, p =0.21, Appendix Figure 3).  
 
Differences in Macular Thickness and Volume 
 
 
For macular thickness (MT), four studies (3 SZ and 1BD) were included for a total of 185 eyes 
from probands (162 SZ and 23 BD) and 177 eyes from HC (154 from SZ and 23 from BD 
studies). No significant reductions in thickness were seen (SMD = -0.61, CI = 1.46 to 0.25, p 
0.11, Figure 9B). After adjustment for publication bias, no significant results arose (SMD = -
0.27, CI = -1.05 to 0.50, p = 0.40, Figure 9B).  
 Four SZ studies, with a total of 252 SZ eyes and 314 HC eyes, were analyzed for 
macular volume (MV) measures. No significant decreases in MV were observed (SMD = -
0.46, CI = -1.60 to 0.69, p = 0.29, Figure 9C). Quantitative adjustment for publication bias via 
the trim and fill method reported a significant reduction in MV between SZ and HC (SMD = 




Figure 9: Meta-analysis data for (A) CT, (B) MT, and (C) MV. Forest plots with fixed and random 
effects as well as SMD are given for RNFL data in probands, SZ (group 1) and BD (group 2). “Total” 
indicates the number of eyes whose measures are used to calculate mean difference. Horizontal bars 
in the forest plot indicate the 95% CI. Size of the square indicates the weight for each study.  
 
Out of all regions, the overall peripapillary RNFL, superior RNFL, and GCL-IPL displayed 
the largest effect sizes between probands and (Figure 10). Smaller but still significant effects 
were seen for the nasal and temporal RNFL. It should be noted that all groups (probands, 
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Figure 10: Forest plot of significant retinal segments and effect size. Circles represent the SMD 
effect size (Cohen’s d), with the horizontal bars indicating the 95% CI. Groups indicate probands 
(overall, SZ, and BD) compared to HC eyes.  
 
 
Pilot Study Analysis 
The demographic data for the 38 participants is listed in Table 2.  The diagnostic groups 
showed no significant differences due to sex, race, and age (! = 2.96, p = 0.40; T= 7.89, p = 
0.25; != 1.33, p = 0.28). No significant group differences were seen for right VA, left VA, or 
overall VA (! = 3.42, p = 0.33; ! = 6.74, p = 0.35; != 1.94, p = 0.14). Trending differences 













Group differences analysis studied via multivariate comparisons for retinal layer data in right 
(OD), left (OS), and mean (OD and OS averaged) measurements. Covariates included age, 
sex, race, BCVA and BMI. For OD analyses, the right VA was used as a covariate, and for OS 
analyses, the left VA was used.  
 
Mean Eye Group Differences 
In mean eye analyses, no significant group differences were seen for the overall retinal 
thickness. The overall RNFL displayed trending thinning in probands compared to HC (t = -
1.72, p = 0.095), and the overall and outer OPL showed trending thickening (t = 1.98, p = 
0.057; t = 2.04, p = 0.051, Figure 11A, Appendix Table 3). Similarly, the SZ diagnostic group 
demonstrated a trending reduction in the overall RNFL (t = -1.99, p = 0.058) and increases in 
overall, inner, and outer OPL thickness (t = 2.82, p = 0.009; t = 2.18, p = 0.040; t = 2.87, p 
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= 0.008, Figure 11B, Appendix Table 3). The BD group showed a trending decrease in central 
RNFL thickness (t = -2.08, p = 0.060, Figure 11C, Appendix Table 3).  
 
Figure 11: T-stat heat map of mean retinal layer differences. Sub-maps are for (A) probands vs. 
HC, (B) SZ vs. HC, and (C) BD vs. HC. Darker red color indicates higher thickness in probands 
compared to controls, while a darker blue color indicates lower thickness. Statistically significant 
results are indicated with: (a) ‘-‘ for p < 0.1, (b) ‘*’ for p < 0.05, (c) ‘**’ for p < 0.01, and (d) ‘***’ for 
p < 0.001. 
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Right Eye Group Differences 
No significant changes in retinal layers were seen in proband and SZ groups compared to HC 
for right eye retinal measures (Figures 12A and 12B). In the BD group, the central RNFL 









Figure 12. T-stat heat map of right eye retinal layer differences in (A) probands vs. HC, (B) SZ 
vs. HC, and (C) BD vs. HC. Darker red color indicates higher thickness in probands compared to 
controls, while a darker blue color indicates lower thickness. Statistically significant results are indicated 
with: (a) ‘-‘ for p < 0.1, (b) ‘*’ for p < 0.05, (c) ‘**’ for p < 0.01, and (d) ‘***’ for p < 0.01. 
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Left Eye Group Differences 
For probands, the left eye showed significant thickening of the overall, inner, and outer OPL 
(t = 2.08, p = 0.046) and a trending thinning of the inner and outer ONL (t = -1.8, p = 0.082, 
Figure 13A, Appendix Table 4). In SZ eyes, there were increases in overall, inner, and outer 
OPL thickness (t = 2.56, p = 0.017; t = 2.57, p = 0.017; t = 2.57, p = 0.017, Figure 13B, 
Appendix Table 5) as well as trending reductions in the overall, inner, and outer ONL (t = -
1.88, p = 0.072; t = -2.03, p = 0.054; t = -2.03, p = 0.054, Figure 13B, Appendix Table 5). BD 
eyes displayed trending increases in inner and outer RNFL (t = 2.02, p 0.065) and trending 






Figure 13. T-stat heat map of left eye retinal layer differences.  in (A) probands vs. HC, (B) SZ 
vs. HC, and (C) BD vs. HC. Darker red color indicates higher thickness in probands compared to 
controls, while a darker blue color indicates lower thickness. Statistically significant results are indicated 




Clinical Correlations  
Clinical measures such as illness duration, PANSS total and positive/negative symptom total 
scores, antipsychotic dosage, and smoking status were analyzed for correlation to retinal layer 
thickness. Covariates of age, sex, race, BMI, and VAC were used in all analyses, with the 
exception of antipsychotic dosage due to small sample size.  
 Illness duration, PANSS score, and PANSS positive subscore did not show any 
significant correlations to retinal layer thickness (Figures 14 A-C). PANSS negative total score 
demonstrated a significant negative correlation with overall GCL thickness (t = -2.33, p = 
0.048) as well as trending negative relationships with the central RNFL, inner GCL, and outer 
GCL (t = -1.90, p = 0.09; t = =1.92, p = 0.091; t = -1.91, p = 0.09, Figure 14D, Appendix 
Table 8). Average chlorpromazine dosage showed a trending positive correlation to overall 
retinal thickness (t = 2.42, p = 0.06). In addition, there was an inverse relationship between 
antipsychotic dosage and overall and outer IPL (t = -2.27, p = 0.072; t = -2.28, p = 0.071, 
Figure 14E, Appendix Table 10). Finally, no correlations were observed between retinal 




Figure 14. Clinical association t-stat heat map. Clinical measures include (A) illness duration, (B) 
PANSS total score, (C) PANSS positive symptom score, (D) PANSS negative symptom score, (E) 
average chlorpromazine dosage, and (F) smoking status. Darker red color indicates higher thickness in 
probands compared to controls, while a darker blue color indicates lower thickness. Statistically 
significant results are indicated with: (a) ‘-‘ for p < 0.1, (b) ‘*’ for p < 0.05, (c) ‘**’ for p < 0.01, and (d) 





Structural MRI Correlations  
Total gray matter thickness, gray matter volume, and intracranial volume were analyzed for 
correlations to retinal layer thickness.  Figure 15 illustrates correlation heat maps of the t 
statistics for mean retinal layer and cortical measures. A trending positive relationship was 
observed between ICV and the outer total retinal thickness (t = 1.92, p = 0.07, Figure 15A, 
Appendix Table 12). A significant inverse relationship was found between total GM thickness 
and inner RNFL (t = -2.17, p = 0.04, Figure 15B, Appendix Table 12). The outer GCL 
displayed a slight slight trending negative relationship with ICV (t = -1.76, p = 0.09, Figure 
15C, Appendix Table 12). No correlations were seen between the cortical measures and IPL 
or the INL (Figures 15D and 15E, Appendix Table 12). The inner and overall regions of the 
OPL showed a significant and trending negative correlation with ICV, respectively (t = -2.72, 
p = 0.01; t = -1.83, p = 0.08). In addition, the inner OPL and GM volume had a trending 
negative correlation (t = -1.79, p = 0.088, Figure 14F, Appendix Table 12). Lastly, the central 
ONL showed a trending negative correlation with the total GM thickness (t = -1.95, p = 0.066, 






















Figure 15. Cortical-retinal structure association t-stat heat map.  Sub-figures represent heatmaps 
for (A)Total retina, (B) RNFL, (C) GCL, (D) IPL, (E) INL, (F) OPL, (G) ONL. Darker red color 
indicates higher thickness in probands compared to controls, while a darker blue color indicates lower 
thickness. Statistically significant results are indicated with: (a) ‘-‘ for p < 0.1, (b) ‘*’ for p < 0.05, (c) 







Disclaimer: This section has been adapted from the author’s co-first author publication: 
Lizano, P., Bannai, D., Lutz, O., Kim, L. A., Miller, J., & Keshavan, M. (2020). A Meta-
analysis of Retinal Cytoarchitectural Abnormalities in Schizophrenia and Bipolar Disorder. 
Schizophrenia Bulletin, 46(1), 43–53. https://doi.org/10.1093/schbul/sbz029. Overall, the 
meta-analysis established that compared to HC, there is significant atrophy in the overall and 
nasal RNFL related to psychosis. Significant thinning of the temporal RNFL was found in 
the proband and SZ group, while reductions in superior and inferior RNFL were only seen 
in BD eyes. In addition, significant reductions of the GCL-IPL were observed across 
proband, SZ, and BD groups, while GCC thinning was only seen in BD. No differences 
were found for the GCL. In addition, MT and CT measures showed no differences between 
groups. Finally, significant reductions in MV were found for the SZ group. All findings were 
cross-validated and controlled and adjusted for publication bias. Furthermore, meta-
regression analysis into age, sex, disease duration, OCT device and NOS score were found to 
be unrelated to RNFL, GCL-IPL, or choroidal thickness.  
The RNFL findings are of significant interest since it contains unmyelinated ganglion 
cell axons that parallel to the surface of the retina and converge to form the optic nerve. 
These fibers project mainly to the LGN of the thalamus and therefore are the main sensory 
input to the visual cortex (Mancall & Gray, 2011). Damage can occur at any point in the 
visual pathway resulting in atrophy of ganglion cells and their axons (GCL and RNFL, 
respectively) in a retrograde process (Petzold et al., 2016). The concept of retrograde trans-
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synaptic degeneration (RTSD) has been well documented in animal models, where 
destruction of the occipital lobe was associated with decreases in thalamic LGN cells, thus 
leading to decreases in retinal ganglion cell density (Dinkin, 2017). In human models, a study 
by Gabilondo et al. (2014) supported the presence of RTSD in the posterior visual pathway 
in patients with MS, a disease characterized by chronic axonal degeneration.  
 The thalamus plays an important role in the pathophysiology of SZ and BD. It is the 
central relay center between sensory information and cortical regions such as the cerebral 
cortex and cerebellum, that control various cognitive functions (Dorph-Petersen & Lewis, 
2017). Literature shows that the thalamus is largely affected in SZ and BD through 
alterations in volume, structural connectivity, activation, and cell number (Cho et al., 2019; 
Dorph-Petersen & Lewis, 2017; Ng et al., 2009). It can be hypothesized that inflammatory or 
oxidative stress pathways in addition to aberrations in microvasculature may lead to RTSD 
and retinal layer atrophy, but no studies have tested this in SZ or BD.  
 
RNFL  
The overall and superior RNFL showed the largest effect size differences in thickness 
between probands and HC. The nasal and superior RNFL showed significant thinning in 
both SZ and BD groups. Five articles showed significant reductions in RNFL thickness due 
to illness duration (Chu et al., 2012; Kalenderoglu et al., 2016; Lee et al., 2013; Mehraban et 
al., 2016; Polo et al., 2018). However, six articles showed no relationship (Ascaso et al., 2015; 
Celik et al., 2016; Garcia-Martin et al., 2018; Khalil et al., 2017; Steven M. Silverstein et al., 
2017; Topcu-Yilmaz et al., 2018). The sample from articles containing RNFL measures had 
mixed chronic and acute disease states. While the meta-regression showed no effects of 
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illness duration on RNFL thickness, a separate analysis into acute vs. chronic states could 
not be done because half of the studies combined these two groups. Symptom severity was 
sparsely reported and not analyzed for meta-regression. Kalenderoglu et al. (2016) found an 
association between RNFL thinning and symptom severity, while the other 11 articles found 
no such relationship. Ascaso et al. (2015) proposed that neuro-inflammation in acute 
psychotic states may increase RNFL thickness and thus mask the decreases seen in chronic 
patients. Age, sex, and OCT device were confounders that did not have any correlation with 
RNFL thickness. However, reductions in RNFL thickness with age have been well 
documented (Demirkaya et al., 2013). Variables that have been shown to be cofounders but 
not tested due to small sample size included medication (dosage), smoking, and cardio-
metabolic disease. Silverstein et al. (2017) demonstrated that the presence of diabetes and 
hypertension was associated with a significant reduction in RNFL thickness. This association 
has been seen in previous studies (Garcia-Martin et al., 2017; Zarei et al., 2017). Silverstein et 
al. (2017) did not see any significant correlation between antipsychotic dosage and RNFL 
thickness, and Mehraban et al. (2016) did not demonstrate any effects from smoking. 
 
GCL-IPL, GCC, and GCL  
The GCL rests below the RNFL and is comprised of ganglion cell bodies, astrocytes, and 
amacrine cells. Advances in OCT technology from first generation TD-OCT to second and 
third generation SD- and SS-OCT have allowed for better segmentation of the GCL. The 
IPL contains the synapses of the dendrites of the ganglion cells and the axons of the bipolar 
and amacrine cells. The ganglion cell processes project to the LGN of the thalamus, and 
therefore, decreases in GCL and IPL thickness may reflect neuronal or synaptic atrophy.  
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 Saidha et al. (2013) proposed that the GCL and IPL are better markers of disease 
severity in MS compared to the RNFL, likely due to the fact that the RNFL is sensitive to 
inflammatory effects. The results of the meta-analysis demonstrate a reduction in GCC and 
GCL-IPL, suggesting that the two layers are involved in the pathophysiology of SZ and BD. 
Because the sample size of these analyses contained four or fewer articles, further studies are 
required to determine which layer is most affected and to what degree.  
 No significant relationships between each of these three regions and age, sex, and 
OCT device were seen. Other clinical measures were not able to be analyzed with meta-
regressions due to a small sample size. One study observed correlations between lower GCL 
and IPL volumes and illness duration and symptom severity (Celik et al., 2016). Garcia-
Martin et al. (2018), however, found a significant positive correlation between GCL volume 
volume and illness duration, while Khalil et al. (2017) found no associations between GCC 
thickness and illness duration or symptom severity. Another study showed that the average 
GCL-IPL thickness was decreased in patients with cardio-metabolic issues (hypertension or 
diabetes) but no conclusive relationship could be established due to small sample size 
(Silverstein et al., 2017). With regards to smoking, no articles found differences in GCL 
volume (Kalenderoglu et al., 2016). While further studies are warranted, it can be 
hypothesized that neuronal and synaptic loss, strongly linked to the pathophysiology of SZ 






 The choroid contains a complex vascular bed and supplies the outer retinal layers with 
nutrients, in addition to maintaining the temperature and volume of the eye (Mancall & 
Gray, 2011). The choroid also houses immunoreactive cells (Ehrlich et al., 2010). No 
significant findings were seen in CT from the meta-analysis between probands and HC. 
Celik et al. (2016) found significant reductions in CT in treatment refractory probands 
compared to those who were treatment responsive. Furthermore, they found that CT was 
negatively correlated with symptom severity. However, Topcu-Yilmaz et al. (2018) reported 
a slight correlation between CT and illness duration. Because the findings are mixed, further 
studies are required to clarify the role of CT in SZ and BD. 
 
Macula  
Very few studies included macular volume or thickness, and no studies included macular 
segmentation. After adjustment for publication bias, significant reductions in MV were seen 
in probands compared to HC. No significant correlations were seen for illness duration, 
symptom severity, or any other clinical measure (Ascaso et al., 2015; Chu et al., 2012). 
Because of the small sample size (n=2) for these analyses, further investigation is necessary 
to better understand the role of the macula in SZ and BD.  
 
Limitations 
This meta-analysis has several limitations associated. First, the total number of studies 
(n=12) is small, and the data from these papers varied in the retinal segmentation measures 
reported. For example, reporting of the GCL-IPL measure was variable, so the GCL, IPL, 
and GCL-IPL data was pooled in order to increase statistical power. Some studies included 
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right and left eye data, which was pooled for a mean value, while other studies reported data 
from one eye. Other limitations included heterogeneity in the studies included, variability in 
OCT device used, and publication bias. These were addressed in the meta-analysis by 
utilizing random effects models when necessary, performing cross-validation analysis, 
adjusting for publication bias via the trim and fill method, and conducting a meta-regression 
analysis for OCT device. 
 
Pilot Study Findings 
The results of the meta-analysis gave information on which regions to specifically look at in 
the preliminary analysis, namely the RNFL and GCL-IPL. In addition, it provided a 
comprehensive review of the current literature relating to retinal imaging in psychosis. 
However, the papers in the meta-analysis only provided measures for three of eight layers 
(RNFL, GCL, and IPL) in addition to CT. Only a few analyzed relevant clinical measures 
such as smoking status, illness duration, and antipsychotic dosage. There was also variation 
in the data measures presented in each article, where some reported averaged right and left 
eye measures and others reported only right or left eye measures as representative for both 
eyes. Lastly, no articles analyzed correlations between neuroimaging and retinal layer 
measures. The pilot study was aimed to replicate previous findings and to fill in 
informational gaps present in literature. 
 Overall, the preliminary found trending reductions in the RNFL, increases in the 
OPL, and reductions in the ONL. No changes in thickness were seen for the GCL, IPL, or 
INL. For the clinical measures, the PANSS negative total score showed a negative 
relationship with GCL thickness, and antipsychotic dosages demonstrated a negative 
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relationship with IPL thickness. Finally, for neuroimaging measures, negative correlations 
were observed between the gray matter thickness and RNFL and ONL thickness, and the 
OPL saw a negative relationship with total ICV.  
Overall Retina 
The total retinal thickness showed no significant differences between proband SZ, and BD 
eyes compared to healthy controls in mean, right, and left eye measurements. 
 Antipsychotic dosage demonstrated a trending positive correlation with overall 
retinal thickness, with a general trend seen across the central, inner, and outer regions. 
Medication has been shown to have an anti-inflammatory in SZ (Li & Xu, 2007), and this 
neuro-protective effect could be what is seen from the positive correlation with the overall 
retinal thickness. PANSS total score and positive symptom score showed a positive trend 
with retinal layer thickness. PANSS negative score displayed a negative relationship between 
retinal layer thickness. This finding is consistent with associations seen between thinning of 
the prefrontal cortex and negative symptom severity in SZ (Walton et al., 2018).  Moreover, 
it supports the RTSD hypothesis linking reductions in cortical measures to reductions in 
retinal layer thickness. 
A trending positive correlation was observed between the outer retinal thickness and 
total ICV. All sub-regions of total retinal thickness demonstrated a positive trend with GM 
thickness, GM volume, and total ICV. This is expected, as retinal thickness would correlate 





Overall, slight trending reductions were seen in the overall RNFL in probands and SZ eyes 
compared to HC eyes. No significant differences in any region of the RNFL were seen in the 
right eye, while the left eye showed trending increases in the inner and outer RNFL 
reductions in the central RNFL. These results are consistent with the meta-analysis and 
literature showing RNFL atrophy in psychosis.  
The increase in thickness observed in the left eye may be explained by a neuro-
inflammatory response. The role of neuro-inflammation in the pathophysiology of psychotic 
disorders has recently been well-studied. Aricioglu et. al (2016) demonstrated that various 
inflammatory marker increases are associated with SZ, including increases in peripheral 
cytokine levels (namely, interleukin-6, tumor necrosis factor ", and C-reactive protein), 
hyperactivation and damaged functionality of astrocytes, and disturbances in monocytic 
immune responses. In bipolar disorder, similar elevations in peripheral cytokine levels and 
glial dysfunctions have been observed (Muneer, 2016). These disruptions can alter the 
permeability of the blood brain barrier (BBB), causing disruption and leading to changes in 
the retinal layer measurements. 
 Clinical measures such as illness duration, PANSS total score, PANSS positive 
symptom score, antipsychotic medication dosage, and smoking status showed no 
relationship to RNFL thickness. Past studies have shown similar results (Mehraban et al., 
2016; Silverstein & Keane, 2011). A trending inverse relationship between PANSS negative 
symptom score and central RNFL thickness was observed. Kalenderoglu et al. (2016) found 
a negative relationship between symptom severity and global RNFL thickness. However, 
their symptom measures included the Young Mania Rating Scale (YMRS) and Clinical 
Global Impression (CGI), not PANSS.  
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With regards to cortical measures, the inner RNFL showed a significant inverse 
correlation with total gray matter thickness. This result is contradictory to previous literature 
supporting a positive relationship between RNFL and GM thickness and could be due to the 
small sample size.   
 
GCL and IPL 
No significant differences were observed in the GCL and IPL in probands, SZ, or BD 
compared to HC for mean, left, and right eye values. This is inconsistent with the meta-
analysis GCL-IPL reduction finding, even if GCL and IPL measures were not combined in 
the preliminary analysis. 
The GCL showed a general negative relationship to duration of illness, PANSS 
negative score, antipsychotic dosage, and smoking but did display a positive relationship with 
PANSS positive score. Garcia-Martin et al. (2018) found a similar negative relationship 
between GCL thickness and disease duration. Celik et al. (2016) reported negative 
correlations between total PANSS score and illness duration to the right GCL. 
 The IPL demonstrated no correlation with illness duration, PANSS total score, 
PANSS positive score, PANSS negative score, and smoking status. A trending inverse 
relationship between the overall and outer IPL antipsychotic was observed. Celik et al. 
(2016) found a strong negative correlation between right IPL thickness and disease duration 
and total PANSS score and was the only study to report any IPL thickness relationship to 
clinical measures. 
The overall GCL had a negative relationship with all three cortical measures, with the 
correlation between outer GCL and ICV being both negative and trending. Furthermore, the 
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IPL showed an overall negative relationship with GM thickness and volume and ICV. While 
not significant, these trends contradict the association of retinal and cortical integrity.    
INL, OPL, and ONL 
The INL, OPL, and ONL were not included in the meta-analysis because not enough 
articles collected and reported these measures. From the preliminary analysis, no significant 
thickness differences were found for the INL in probands, SZ, and BD compared to HC. 
Trending increases in the overall and outer OPL thickness was observed in probands and SZ 
eyes compared to HC eyes. Furthermore, the SZ group showed significant thickening of the 
inner OPL. Left eye overall, inner, and outer OPL measures were found to be significantly 
increased in probands. Right eye overall, inner, and outer OPL were observed in SZ. Samani 
et al. (2018) had similar but not significant findings that demonstrated increases in OPL 
thickness in SZ. In addition, thickening of the OPL has been observed in Parkinson’s disease 
with the suggestion that foveal remodeling from oxidative stress pathways may explain the 
findings (Chorostecki et al., 2015; Pilat et al., 2016). Finally, the inner and outer ONL saw 
trending thinning in probands compared to HC, which is consistent with what was observed 
by Samani et al. (2018).   
No significant correlations were found between all three layers and clinical measures.  
With regards to cortical measures, no correlations were determined with the INL. The OPL 
demonstrated a significant negative relationship with total ICV, while the ONL showed a 
trending negative relationship with total gray matter thickness. Samani et al. (2018) found an 
inverse relationship between ONL thickness and PANSS negative symptom score but did 
not report any cortical correlations between any of these three layers.  
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 Few studies have reported on INL, OPL, and ONL thickness differences due to 
limitations in retinal segmentation resolution in older generation OCT devices. Now with 
SD- and SS-OCT, these layers are more easily and reliably parsed out. Further investigation 
into the changes in these layers is warranted, since these findings are novel in not only 
psychiatric disorders such as SZ or BD but also in neurologic disorders in general. 
 
Limitations 
One limitation for this exploratory analysis is a small sample size (n=38). Increasing the 
power for this study would greatly increase the confidence to which the results may be 
interpreted, and active recruitment is underway for this study. Further studies expanding the 
number of  cortical measures analyzed would help to better test the RTSD hypothesis, 
especially in the thalamic region and its related structures.   
 
Conclusion 
In all, the use of OCT to study the underlying neurobiology of SZ and BD shows promising 
results. Visual impairments are observed in psychosis in addition to many neurologic 
disorders and reflected in abnormalities in retinal layers, seen with the use of OCT. Because 
of the connection between retinal layers and the thalamus and its higher order projections, 
ocular biomarkers may shed light on early degenerative mechanisms in psychosis. 
Furthermore, they may reflect pathophysiologies without the need to image with an MRI, 
which is both costly and time-consuming.  
From an initial meta-analysis of twelve articles, the RNFL, GCL-IPL, and choroid 
showed significant reductions in thickness. An initial pilot study found reductions in the 
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RNFL and ONL, as well increases in the OPL. Thinning seen within the RNFL and OPL 
reflect neuronal synaptic atrophy, and remodeling observed from increased OPL thickness 
may demonstrate pathologic neuro-inflammatory mechanisms.  
Finally, thesis has shown the need for further investigations in retinal 
cytoarchitectural changes in SZ and BD. Increasing the sample size from this pilot study 
would increase power and allow for more definitive conclusions from the results. 
Furthermore, analyzing structural connectivity between the LGN of the thalamus and 
thalamic projections and retinal layer measures would illuminate RTSD and the mechanisms 












Appendix Figure 1: RNFL funnel plots. Funnels plots are for (A) overall, (B) nasal, (C) temporal, 
(D) superior, and (E) inferior RNFL regions in probands compared to controls. The green line 















Appendix Figure 2: Ganglion cell layer funnel plots. Funnels plots are for (A) GCL-IPL, (B) 
GCC, and (C) GCL regions in probands compared to controls. The green line indicates the overall 





Appendix Figure 3: Funnel plots for choroid and macula regions. Funnels plots are for (A) CT, 
(B) MT, and (C) MV regions in probands compared to controls. The green line indicates the overall 
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